Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin

Bone Marrow Transplantation

Volumn 20, Issue 12, 1997, Pages 1105-1107

  Santamaria A ^a   Sureda, A ^a   Martino, R ^a   Domingo Albos A ^a   Muniz Diaz E ^a   Brunet, S ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

ABO incompatible BMT; Erythropoietin; Pure red cell aplasia

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CASE REPORT; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PURE RED CELL ANEMIA;

EID: 0031451084     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701012     Document Type: Article

References (13)

1. Klumpp TR. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991; 8: 159-170.
2. Sniecinski IJ, Oien L, Petz LD, Blume G. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530-534.
3. Bär B, Van Dijk BA, Schattenberg A et al. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow. Bone Marrow Transplant 1995; 16: 793-799.
4. Or R, Naparstek E, Mani N, Slavin S. Treatment of pure red cell aplasia following major ABO-mismatched T cell-depleted bone marrow transplant. Transplant Int 1991; 4: 99-102.
5. Marmont AM, Frassoni F, van Lint MT et al. Isohemagglutinin-induced pure red cell aplasia following major ABO incompatible marrow transplant for severe aplastic anemia. Resolution after plasma exchange. Exp Hematol 1983; 11 (Suppl. 13): 51-53.
6. Labar B, Bogdanic V, Nemet D et al. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant. Bone Marrow Transplant 1992; 10: 471-472.
7. Ohashi K, Akiyama H, Takamoto S et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplant 1994; 13: 335-336.
8. Bierman PJ, Warkentin P, Hutchins M, Klassen L. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin. Leuk Lymphoma 1990; 9: 169-171.
9. Gmür JP, Burger J, Shaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290-295.
10. Roychowdhury DF, Linker CA. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 1995; 16: 471-472.
11. Heyll A, Aul C, Runde V et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 1991; 77: 906.
12. Paltiel O, Cournoyer D, Rybka W. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion 1993; 33: 418-421.
13. Taniguchi S, Yamasaki K, Shibuya T et al. Recombinant human erythropoietin for long-term persistent anemia after major anemia after major ABO-incompatible bone marrow transplantation. Bone Marrow Transplant 1993; 12: 423.